Breaking News Instant updates and real-time market news.

GILD

Gilead

$81.82

1.03 (1.27%)

, ABBV

AbbVie

$113.08

(0.00%)

09:44
02/15/18
02/15
09:44
02/15/18
09:44

Lawmakers to push for hep C drug patents being taken, Capitol Forum says

Representative Ro Khanna and 10 other Congress members plan to send a letter urging HHS Secretary Alex Azar to use his legal authority to take patents for hepatitis C virus drugs, according to The Capitol Forum, citing word from Khanna's office. Makers of hep C drugs include Gilead (GILD) and AbbVie (ABBV). Reference Link

GILD

Gilead

$81.82

1.03 (1.27%)

ABBV

AbbVie

$113.08

(0.00%)

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

GILD Gilead
$81.82

1.03 (1.27%)

01/31/18
JEFF
01/31/18
NO CHANGE
JEFF
Jefferies sees neutral impact on Biotech from State of the Union
Jefferies analyst Michael Yee sees a net neutral impact on Biotech stocks from President Trump's State of the Union speech last night. During the speech, Trump made comments about making lower drug prices a "priority" for the year, Yee tells investors in a research not titled "Drug Pricing Comments Not New or Surprising - But a Reminder of Rhetoric." The President, however, also commented on broader access to novel clinical trial drugs, Yee points out. After a "strong biotech rally" in January, the analyst assumes the sector, "at some point," will have some relative near-term pullback either on uncertainty about Trump commentary or some consolidation. Some of the analyst's Buy-rated names include AbbVie (ABBV), Amgen (AMGN), Eli Lilly (LLY) and Gilead Sciences (GILD).
02/07/18
SBSH
02/07/18
NO CHANGE
Target $105
SBSH
Buy
Gilead should be bought ahead of pipeline catalysts, says Citi
Citi analyst Robyn Karnauskas raised her price target for Gilead Sciences to $105 from $103 following last night's Q4 results. The analyst recommends buying the stock ahead of pipeline catalysts and keeps a Buy rating on the name. The base business seems to be stabilizing while gene therapy could be a potential growth area, Karnauskas tells investors in a post-earnings research note.
02/08/18
MSCO
02/08/18
NO CHANGE
MSCO
Equal Weight
Gilead Biktarvy approval, Glaxo patent suit not surprising, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison said investors expected Gilead (GILD) to receive FDA approval for its once-daily single tablet regimen to treat HIV-1 infection, now named Biktarvy, so he would expect limited impact on the stock from the news. He also said GlaxoSmithKline's (GSK) filing of patent infringement litigation alleging that Biktarvy infringes on ViiV's dolutegravir is not a surprise given prior comments by GSK and he would expect this to work through the courts. Harrison, who added that Biktarvy's clean label is a positive, keeps an Equal Weight rating on Gilead shares.
02/09/18
WELS
02/09/18
NO CHANGE
WELS
Outperform
Gilead should be bought on patent challenge weakness, says Wells Fargo
Wells Fargo analyst Jim Birchenough recommends buying Gilead Sciences on weakness following a patent infringement lawsuit against recently approved single tablet regimen Biktarvy for HIV. The analyst believes that Biktarvy patents will hold up to challenge and that the lawsuit will not impact launch or longer term value creation. He remains confident in Gilead's growth beyond "trough earnings" in 2018 and keeps an Outperform rating on the stock.
ABBV AbbVie
$113.08

(0.00%)

01/30/18
01/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AbbVie (ABBV) downgraded to Underperform from Market Perform by analyst Alex Arfaei, who said the risk/reward has "meaningfully changed" after the rise in the stock price, adding that the new focus on fundamentals beyond the benefits of tax reform suggests "significant price erosion in immunology driven by interchangeable biosimilar anti-TNFs, and lower effectiveness of the 'Rebate Trap' to block access to cheap biosimilars". 2. iRobot (IRBT) downgraded to Neutral from Buy at Sidoti by analyst Frank Camma, who cited valuation as shares approach his $98 price target. 3. Horizon Global (HZN) downgraded to Market Perform from Outperform at BMO Capital by analyst Gerrick Johnson, who said that while he still sees "strong demand in key end markets," operation execution, rising input costs, and high debt levels are concerning. The analyst added that the company may have "lost the faith of investors" after a 30% drop in the stock price following the guidance cut. 4. Yum! Brands (YUM) downgraded to Neutral from Buy at Nomura Instinet by analyst Mark Kalinowshi, who cited valuation and concerns a possible 2018 slowdown in U.S. same-store-sales. 5. Alaska Air (ALK) downgraded to Underweight from Neutral at JPMorgan by analyst Jamie Baker, who noted that the airline is the only name where he had to cut his 2019 estimates. He also believes the company "remains in the United crosshairs in San Francisco." The analyst also downgraded Southwest (LUV) to Neutral from Overweight, and said he believes better relative value exists elsewhere in the Airlines sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/02/18
ARGS
02/02/18
NO CHANGE
Target $145
ARGS
Buy
AbbVie price target raised to $145 from $120 at Argus
Argus analyst David Toung raised his price target on AbbVie to $145 and kept his Buy rating after a "solid" Q4 earnings report that also included a substantial boost from lower tax rates. Toung says AbbVie is likely to submit more applications for new products and expanded indications of existing drugs this year as it develops new growth drivers such as Imbruvica and Mavyret to complement the current large contribution from Humira.
02/05/18
JEFF
02/05/18
NO CHANGE
Target $25
JEFF
Hold
Acorda remains takeover candidate after competitor data, says Jefferies
Jefferies analyst Michael Yee believes the positive Phase III topline results from Acorda Therapeutics (ACOR) competitor Sunovion for APL-130277 in Parkinson's patients came in as expected. While APL-130277 data compares favorably over Inbrija's 3.92 point difference at week 12, Yee cautions to compare directly head-to-head since patient baseline characteristics could be different. Acorda remains a "reasonably likely" acquisition candidate in 2018 given its $300M-$500M-plus Parkinson's asset Inbrija, Yee tells investors in a research note. The analyst does not think Biogen (BIIB) should buy the company, but sees other potential suitors in AbbVie (ABBV), Allergan (AGN), Mitsubishi, Roche (RHHBY) and Shire (SHPG). He believes a takeover price could be north of $2B. Yee keeps a Hold rating on Acorda with a $25 price target.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

19:48
12/11/18
12/11
19:48
12/11/18
19:48
Periodicals
Trump may intervene in Huawei CFO arrest to get China trade deal, Reuters says »

In an interview with…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$0.00

(0.00%)

19:33
12/11/18
12/11
19:33
12/11/18
19:33
Syndicate
Tencent Music 82M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TME

Tencent Music

$0.00

(0.00%)

19:26
12/11/18
12/11
19:26
12/11/18
19:26
Syndicate
Breaking Syndicate news story on Tencent Music »

Tencent Music prices IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CRM

Salesforce

$136.83

-0.46 (-0.34%)

19:25
12/11/18
12/11
19:25
12/11/18
19:25
Conference/Events
Salesforce management to meet with Goldman Sachs »

Alex Dayon, President and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

  • 03

    Mar

O

Realty Income

$66.30

0.58 (0.88%)

19:06
12/11/18
12/11
19:06
12/11/18
19:06
Hot Stocks
Realty Income raises monthly dividend to 22.1c per share from 22.05c »

Realty Income Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$67.28

0.06 (0.09%)

19:02
12/11/18
12/11
19:02
12/11/18
19:02
Hot Stocks
Black Hills buys 50% interest in Busch Ranch I Wind Farm »

Black Hills Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$15.66

-0.36 (-2.25%)

, PVTL

Pivotal Software

$17.80

-0.23 (-1.28%)

18:59
12/11/18
12/11
18:59
12/11/18
18:59
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

AXNX

Axonics

$15.66

-0.36 (-2.25%)

PVTL

Pivotal Software

$17.80

-0.23 (-1.28%)

HAIN

Hain Celestial

$18.80

-0.38 (-1.98%)

URI

United Rentals

$101.89

0.02 (0.02%)

VKTX

Viking Therapeutics

$9.47

0.01 (0.11%)

FSLR

First Solar

$42.43

-0.79 (-1.83%)

JAZZ

Jazz Pharmaceuticals

$140.46

0.9 (0.64%)

SEIC

SEI Investments

$48.50

-0.64 (-1.30%)

BEN

Franklin Resources

$31.53

-0.52 (-1.62%)

PLAY

Dave & Buster's

$51.08

-1.44 (-2.74%)

AEO

American Eagle

$19.03

-0.49 (-2.51%)

ARWR

Arrowhead

$13.61

-0.05 (-0.37%)

MRNS

Marinus Pharmaceuticals

$5.10

-0.14 (-2.67%)

FLDM

Fluidigm

$7.58

-0.11 (-1.43%)

TOCA

Tocagen

$12.85

0.2 (1.58%)

LAND

Gladstone Land

$13.33

-0.16 (-1.19%)

ANGI

Angi Homeservices

$16.62

-0.11 (-0.66%)

BAC

Bank of America

$24.58

-0.17 (-0.69%)

MS

Morgan Stanley

$40.62

-0.07 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

  • 20

    Dec

  • 12

    Feb

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

, BSX

Boston Scientific

$36.55

0.41 (1.13%)

18:47
12/11/18
12/11
18:47
12/11/18
18:47
Hot Stocks
Edwards says does not expect to pay $35M award in Boston Scientific case »

Edwards Lifesciences (EW)…

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

BSX

Boston Scientific

$36.55

0.41 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RARX

RA Pharmaceuticals

$15.97

-1.61 (-9.16%)

18:41
12/11/18
12/11
18:41
12/11/18
18:41
Syndicate
RA Pharmaceuticals 8.4M share Secondary priced at $15.50 »

Jefferies, BMO Capital,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

HTLF

Heartland Financial

$49.30

-0.24 (-0.48%)

18:38
12/11/18
12/11
18:38
12/11/18
18:38
Hot Stocks
Heartland Financial announces special cash dividend of 5c »

Heartland Financial USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$16.62

-0.11 (-0.66%)

18:24
12/11/18
12/11
18:24
12/11/18
18:24
Syndicate
Angi Homeservices 1.5M share Spot Secondary priced at $16.40 »

The deal priced within…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

18:24
12/11/18
12/11
18:24
12/11/18
18:24
Periodicals
Huawei CFO Meng granted bail by Canadian judge, Bloomberg reports »

Huawei Technologies Co.…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.55

0.41 (1.13%)

, EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

18:14
12/11/18
12/11
18:14
12/11/18
18:14
Hot Stocks
Boston Scientific says it 'prevails' in U.S. Edwards Lifesciences litigation »

Boston Scientific (BSX)…

BSX

Boston Scientific

$36.55

0.41 (1.13%)

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MSFT

Microsoft

$108.67

1.11 (1.03%)

18:14
12/11/18
12/11
18:14
12/11/18
18:14
Hot Stocks
Microsoft CMO Chris Capossela sells 4K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GLD

SPDR Gold Shares

$117.55

-0.13 (-0.11%)

18:05
12/11/18
12/11
18:05
12/11/18
18:05
Hot Stocks
SPDR Gold Shares holdings rise to 763.56MT from 760.32MT »

This is the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

18:04
12/11/18
12/11
18:04
12/11/18
18:04
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Huawei CFO Meng granted…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEGY

Siemens

$0.00

(0.00%)

17:56
12/11/18
12/11
17:56
12/11/18
17:56
Periodicals
Siemens to close Texas turbines facility, dismiss 200 workers, Reuters says »

Siemens intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CABO

Cable One

$871.98

9.68 (1.12%)

17:56
12/11/18
12/11
17:56
12/11/18
17:56
Hot Stocks
Cable One to rebrand as Sparklight in the summer of 2019 »

Cable One announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJRD

Aerojet Rocketdyne

$35.40

0.02 (0.06%)

17:53
12/11/18
12/11
17:53
12/11/18
17:53
Hot Stocks
Aerojet Rocketdyne awarded DARPA contract to design OpFires propulsion system »

Aerojet Rocketdyne said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGNC

AGNC Investment

$17.92

0.045 (0.25%)

17:45
12/11/18
12/11
17:45
12/11/18
17:45
Hot Stocks
AGNC Investment reports tangible net book value of $16.76 per share »

AGNC Investment …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$120.40

-0.47 (-0.39%)

, PCRFY

Panasonic

$0.00

(0.00%)

17:40
12/11/18
12/11
17:40
12/11/18
17:40
Periodicals
Breaking Periodicals news story on Toyota, Panasonic »

Panasonic to supply…

TM

Toyota

$120.40

-0.47 (-0.39%)

PCRFY

Panasonic

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$87.28

0.08 (0.09%)

17:37
12/11/18
12/11
17:37
12/11/18
17:37
Hot Stocks
Nasdaq acquires Quandl to 'advance' the use of alternative data »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KL

Kirkland Lake Gold

$24.36

0.58 (2.44%)

17:36
12/11/18
12/11
17:36
12/11/18
17:36
Hot Stocks
Kirkland Lake Gold raises dividend to C$0.04 from C$0.03 »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.55

0.41 (1.13%)

, EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

17:26
12/11/18
12/11
17:26
12/11/18
17:26
Periodicals
Breaking Periodicals news story on Boston Scientific, Edwards Lifesciences »

Boston Scientific wins…

BSX

Boston Scientific

$36.55

0.41 (1.13%)

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HUSA

Houston American Energy

$0.22

0.0009 (0.42%)

17:26
12/11/18
12/11
17:26
12/11/18
17:26
Syndicate
Breaking Syndicate news story on Houston American Energy »

Houston American Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.